Elman Retina Group is a dedicated surgical retina subspecialty practice — our fellowship-trained physicians focus exclusively on diseases of the retina, vitreous, and macula. We offer the full spectrum of medical and surgical retinal care across five Baltimore-area locations.
As a retinal subspecialty practice, ERG treats conditions that general ophthalmologists refer out — from routine macular disease to complex surgical cases.
The leading cause of vision loss in adults over 50. We treat both dry and wet (neovascular) AMD with the latest anti-VEGF therapies and AREDS2 supplementation.
Diabetes can damage retinal blood vessels before symptoms appear. Early detection and treatment prevent up to 95% of diabetes-related vision loss.
A surgical emergency where the retina separates from the back of the eye. Immediate vitrectomy, scleral buckle, or pneumatic retinopexy can save your vision.
A small break in the retina that can progress to detachment. Laser photocoagulation or cryopexy seals the tear in-office, preventing a surgical emergency.
A blockage in the retinal vein causes sudden vision loss and macular edema. Anti-VEGF injections and laser therapy treat vision-threatening complications.
A small defect in the center of the macula causes central vision loss. Vitrectomy with gas tamponade achieves high closure rates and meaningful vision recovery.
Scar tissue on the retinal surface causes distorted or blurry central vision. Vitrectomy with membrane peeling can substantially improve visual function.
Bleeding into the vitreous gel from proliferative diabetic retinopathy, a retinal tear, or trauma. Vitrectomy removes blood and addresses the underlying cause.
Inflammation inside the eye from autoimmune disease or infection. ERG includes dual-fellowship trained specialists in both vitreoretinal surgery and uveitis, providing comprehensive management in coordination with rheumatologists and immunologists.
Genetic conditions like retinitis pigmentosa and Stargardt disease cause progressive vision loss. We offer diagnostic evaluation, genetic counseling referrals, and access to active gene therapy clinical trials.
Natural age-related separation of the vitreous gel. While usually benign, a thorough dilated exam is critical to rule out associated retinal tears.
Performed by fellowship-trained retina surgeons with subspecialty expertise in vitreoretinal surgery, uveitis, and ocular oncology.
Microsurgical removal of the vitreous gel to access and repair the retina. Used to treat retinal detachments, macular holes, epiretinal membranes, vitreous hemorrhage, and diabetic tractional detachments. ERG surgeons perform pars plana vitrectomy with 23-, 25-, and 27-gauge instrumentation.
Our subspecialty surgical retina training distinguishes ERG from comprehensive ophthalmology practices.
Intravitreal injection of anti-VEGF agents is the cornerstone of treatment for wet AMD, diabetic macular edema, and retinal vein occlusion. We offer the full formulary including Eylea, Vabysmo, Lucentis, and Avastin — and work with each patient to optimize dosing intervals.
Eylea (aflibercept) · Vabysmo (faricimab) · Lucentis (ranibizumab) · Avastin (bevacizumab)
Focal and panretinal photocoagulation (PRP) are office-based laser procedures that seal leaking or abnormal retinal blood vessels. PRP is the standard of care for proliferative diabetic retinopathy; focal laser treats macular edema. Used to treat retinal tears and prevent detachment.
A silicone band sutured around the eye to indent the scleral wall against the detached retina, promoting reattachment. Particularly effective for younger patients, phakic eyes, and certain inferior detachments. Often combined with vitrectomy for complex cases.
An office-based procedure for select retinal detachments where a gas bubble is injected into the vitreous and combined with laser or cryopexy to seal the causative tear. When indicated, it avoids the operating room entirely.
Controlled freezing applied to the outside of the eye to seal retinal tears and prevent detachment. Used as an alternative to laser in certain clinical situations, including vitreous hemorrhage where laser visualization is limited.
Sustained-release corticosteroid delivery via injection (triamcinolone) or biodegradable implant (Ozurdex) to treat inflammatory macular edema, uveitis, and vein occlusion. Longer dosing intervals reduce patient burden compared to anti-VEGF alone.
State-of-the-art retinal imaging allows our specialists to detect subtle disease changes, monitor treatment response, and plan surgical intervention with precision.
High-resolution cross-sectional imaging of the retina and choroid. OCT is the most essential tool for diagnosing and monitoring macular diseases. OCT Angiography (OCTA) provides non-invasive mapping of retinal and choroidal vasculature without dye injection.
Intravenous dye-based imaging that reveals blood flow patterns, leaking vessels, ischemia, and neovascularization in real time. Essential for staging diabetic retinopathy and planning laser treatment.
Ultra-widefield color and autofluorescence photography documents the peripheral retina — critical for monitoring diabetic retinopathy, retinitis pigmentosa, and lattice degeneration across visits.
Ultrasound imaging of the eye used when direct retinal visualization is obstructed (e.g., vitreous hemorrhage, dense cataract). Essential for ruling out retinal detachment in opaque media.
Elman Retina Group performs vitreoretinal surgery at accredited facilities equipped with the latest generation vitrectomy systems — ensuring our surgeons have the most advanced tools available for every procedure.
